The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Solutol-HS15     2-hydroxyethyl 12-hydroxyoctadecanoate

Synonyms: Solutol HS 15, NSC-7395, NSC7395, AC1L3ZAM, CTK2F9022, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Solutol HS 15

 

High impact information on Solutol HS 15

  • The properties of three polyethoxylated surfactants that showed the lowest toxicities, Cremophor, Tween 80 and Solutol HS15, were examined in more detail [2].
  • In vitro investigation on the impact of Solutol HS 15 on the uptake of colchicine into rat hepatocytes [3].
  • However, in control experiments performed at 4 degrees C, a temperature at which active transport processes should be significantly slowed down, Solutol HS 15 at 0.03% did not affect colchicine uptake and/or its association with the cells [3].
  • It was found that the oral bioavailability of CyA in the Solutol HS 15-based formulation was twofold higher as compared to the microsuspension (69.9+/-2.8 vs. 35.7+/-3.3%, P=0.001) [4].
  • Improved stability properties conferred to emulsions by alkali fatty acids could be attributed to the zeta potential increase even in the presence of Solutol HS 15 [5].
 

Anatomical context of Solutol HS 15

  • Phototoxicities were calculated by employing a concentration of 10(-7) M of the dye against the Hep-2 cell line, which showed a viability of 53 and 30% in DMPC and Solutol HS 15, respectively [6].
  • The free fraction in rat plasma (FF), the blood/plasma (lambda) and erythrocyte/plasma concentration ratios (K(e)) were not significantly changed in the presence of different concentrations of Solutol HS 15 compared with surfactant-free incubations (overall means: 72.25+/-0.50% for FF, 0.80+/-0.02 for lambda, 0.46+/-0.04 for K(e)) [7].
  • The impact of the surface-active formulation ingredients Cremophor EL, Tween 80 and Solutol HS 15 on the intrinsic clearance (Clint) of midazolam (MDZ) was investigated in rat hepatocytes and microsomes [8].
 

Associations of Solutol HS 15 with other chemical compounds

 

Gene context of Solutol HS 15

  • In rat hepatocytes with 0.003%, 0.03% and 0.3% (w/v) Solutol HS 15 already present in the incubation medium, the Clint was significantly reduced in a dose-dependent manner by about 25%, 30% and 50%, respectively [8].
 

Analytical, diagnostic and therapeutic context of Solutol HS 15

  • MDZ exhibited a high plasma clearance (Cl) of 79 and 92 ml/min/kg (corresponding to a blood Cl of 64 and 75 ml/min/kg), a high volume of distribution (V(d)) of 4.0 and 3.6 l/kg, and an area under the plasma concentration-time curve (AUC(t0-tinf)) of 1062 and 932 h.ng/ml in the control group and in the Solutol HS 15-treated group, respectively [10].
  • In the current investigation, the impact of the surface-active formulation ingredient Solutol HS 15 on the uptake of colchicine into freshly isolated rat hepatocytes was investigated using a centrifugal filtration technique through a silicone oil layer [3].

References

  1. Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance. Coon, J.S., Knudson, W., Clodfelter, K., Lu, B., Weinstein, R.S. Cancer Res. (1991) [Pubmed]
  2. Reversal of multidrug resistance by surfactants. Woodcock, D.M., Linsenmeyer, M.E., Chojnowski, G., Kriegler, A.B., Nink, V., Webster, L.K., Sawyer, W.H. Br. J. Cancer (1992) [Pubmed]
  3. In vitro investigation on the impact of Solutol HS 15 on the uptake of colchicine into rat hepatocytes. Bravo González, R.C., Boess, F., Durr, E., Schaub, N., Bittner, B. International journal of pharmaceutics. (2004) [Pubmed]
  4. Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension. Bravo González, R.C., Huwyler, J., Walter, I., Mountfield, R., Bittner, B. International journal of pharmaceutics. (2002) [Pubmed]
  5. The influence of alkali fatty acids on the properties and the stability of parenteral O/W emulsions modified with solutol HS 15. Buszello, K., Harnisch, S., Müller, R.H., Müller, B.W. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V. (2000) [Pubmed]
  6. A comparative study of the photophysical and phototoxic properties of octakis(decyloxy)phthalocyaninato zinc(II), incorporated in a hydrophilic polymer, in liposomes and in non-ionic micelles. Rodriguez, M.E., Morán, F., Bonansea, A., Monetti, M., Fernández, D.A., Strassert, C.A., Rivarola, V., Awruch, J., Dicelio, L.E. Photochem. Photobiol. Sci. (2003) [Pubmed]
  7. Impact of Solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar rats. Bittner, B., González, R.C., Walter, I., Kapps, M., Huwyler, J. Biopharmaceutics & drug disposition. (2003) [Pubmed]
  8. In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam. Bravo González, R.C., Huwyler, J., Boess, F., Walter, I., Bittner, B. Biopharmaceutics & drug disposition. (2004) [Pubmed]
  9. Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells. Chong, A.S., Markham, P.N., Gebel, H.M., Bines, S.D., Coon, J.S. Cancer Immunol. Immunother. (1993) [Pubmed]
  10. Impact of Solutol HS 15 on the pharmacokinetic behavior of midazolam upon intravenous administration to male Wistar rats. Bittner, B., González, R.C., Isel, H., Flament, C. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V. (2003) [Pubmed]
 
WikiGenes - Universities